which has limited capacity to meet wholesale demand in the current quarter (Q4 in the company’s financial year), Dr Martens will lose wholesale revenue and incur costs. This will cut EBITDA by ...
Shares plunged 30% to a record low in early deals and trading was temporarily suspended on the London Stock Exchange. Dr. Martens also announced CEO Kenny Wilson will step down in March 2025 and ...